Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Humans - Indium Radioisotopes (diagnostic use)

Terms

183Humans
146Indium Radioisotopes (diagnostic use)
125Female
114Male
86Middle Aged
66Adult
60Aged
39Somatostatin (analogs & derivatives)

Associations

Freq.WeightAssociation
128128Humans - Indium Radioisotopes (diagnostic use)
115115Female - Humans
101101Humans - Male
9292Female - Indium Radioisotopes (diagnostic use)
8686Humans - Middle Aged
8585Female - Male
8383Indium Radioisotopes (diagnostic use) - Male
7575Female - Middle Aged
7474Male - Middle Aged
6868Indium Radioisotopes (diagnostic use) - Middle Aged
6666Adult - Humans
6060Aged - Humans
5656Adult - Male
5555Adult - Female
5353Adult - Middle Aged
5252Adult - Indium Radioisotopes (diagnostic use)
5151Aged - Female
5050Aged - Middle Aged
4848Aged - Indium Radioisotopes (diagnostic use)
4646Aged - Male
4343Adult - Aged
3939Humans - Somatostatin (analogs & derivatives)
3737Indium Radioisotopes (diagnostic use) - Somatostatin (analogs & derivatives)
2626Male - Somatostatin (analogs & derivatives)
2626Female - Somatostatin (analogs & derivatives)
2424Middle Aged - Somatostatin (analogs & derivatives)
2020Aged - Somatostatin (analogs & derivatives)
2020Adult - Somatostatin (analogs & derivatives)

Documents par ordre de pertinence
000060 (2009) Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.
000076 (2008) Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.
000110 (2005) Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
000134 (2003) Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck.
000135 (2002) [Scintigraphy by l'Octreoscan in the management of head and neck paragangliomas].
000168 (1999) Factor analysis of dynamic series (FADS) in somatostatin receptor imaging.
000170 (1999) Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy.
000172 (1999) Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
000175 (1998) Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake.
000180 (1998) In vivo inaccessibility of somatostatin receptors to 111In-pentreotide in primary renal cell carcinoma.
000207 (1996) Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
000211 (1995) Somatostatin receptor imaging: a preliminary experience in forty-nine patients.
000227 (1994) Scintiscans and carcinoid tumors.
000058 (2009) Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.
000075 (2008) Prediction and diagnosis of bone metastases in well-differentiated gastro-entero-pancreatic endocrine cancer: a prospective comparison of whole body magnetic resonance imaging and somatostatin receptor scintigraphy.
000125 (2004) Diagnostic management of suspected metastatic thyroid carcinoma: clinical value of octreotide scintigraphy in patients with negative high-dose radioiodine scans.
000132 (2003) Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects.
000147 (2001) Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases.
000154 (2000) Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography.
000158 (2000) 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis.
000163 (1999) Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo.
000174 (1999) 111Indium antimyosin antibody imaging of primary myocardial involvement in systemic diseases.
000176 (1998) Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
000197 (1996) Somatostatin receptor imaging in small cell lung cancer.
000221 (1995) Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
000225 (1994) Somatostatin receptor imaging in non-functioning pituitary adenomas: value of an uptake index.
000239 (1993) Splenectomy in idiopathic thrombocytopenic purpura: its correlation with the sequestration of autologous indium-111-labeled platelets.
000260 (1992) Bronchial clearance of DTPA is increased in acute asthma but not in chronic asthma.
000266 (1991) Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
000282 (1990) Imaging of inflammatory bowel disease (IBD) and scintigraphic assessment of resected colon: comparison of 111 In-oxine and 99mTC HMPAO leucocyte labelling.
000289 (1989) Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies.
000094 (2006) Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
000102 (2006) Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.
000129 (2003) Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
000140 (2002) Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
000142 (2001) Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis.
000144 (2001) Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms.
000146 (2001) Is the thrombopoietin assay useful for differential diagnosis of thrombocytopenia? Analysis of a cohort of 160 patients with thrombocytopenia and defined platelet life span.
000149 (2001) Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy.
000162 (1999) Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy.
000190 (1997) Indium-111 antimyosin scintigraphy before and after coronary bypass surgery: unexpected preoperative myocardial uptakes.
000193 (1997) Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
000199 (1996) Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan.
000210 (1995) [Indium III monoclonal antimyosin antibody scintigraphy for the detection of chronic myocardial infarction apart from the acute phase].
000217 (1995) Indium-111 pentetreotide scintigraphy in malignant lymphomas.
000236 (1993) What factors determine indium-111 antimyosin monoclonal antibody uptake in patients with myocardial infarction?
000237 (1993) Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
000248 (1993) Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.
000263 (1991) The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy.
000267 (1991) Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects.
000273 (1991) Diagnosis of left atrial thrombi in mitral stenosis--usefulness of ultrasound techniques compared with other methods.
000280 (1990) Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA.
000286 (1989) Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.
000292 (1989) Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.
000298 (1988) Indium-111 platelet scintigraphy in carotid disease.
000318 (????) Contribution of scintigraphy to verify the reliability of different preparation processes for enteric coated capsules.
000023 (2012) Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000084 (2007) Pathology underrates colon cancer extranodal and nodal metastases; ex vivo radioimmunodetection helps staging.
000085 (2007) Paraneoplastic ACTH secretion: bronchial carcinoid overlooked by planar indium-111 pentetreotide scintigraphy and accurately localized by SPECT/CT acquisition.
000100 (2006) Low-dose lactulose produces a tonic contraction in the human colon.
000106 (2006) Bone metastases from head and neck paragangliomas: uncommon MR findings in an uncommon condition--report of three cases.
000114 (2005) Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas.
000165 (1999) In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumors.
000169 (1999) Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy.
000183 (1997) [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].
000188 (1997) The site of destruction of autologous 111In-labelled platelets and the efficiency of splenectomy in children and adults with idiopathic thrombocytopenic purpura: a study of 578 patients with 268 splenectomies.
000191 (1997) False-positive somatostatin receptor scintigraphy due to an accessory spleen.
000200 (1996) Left ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome.
000201 (1996) Labeled granulocyte scanning for the diagnosis of infected necrosis in acute pancreatitis: what kind of labeling should be used?
000202 (1996) Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
000206 (1996) Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
000213 (1995) Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma.
000214 (1995) Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe.
000224 (1994) Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
000228 (1994) Pretargetted imaging of colorectal cancer recurrences using an 111In-labelled bivalent hapten and a bispecific antibody conjugate.
000229 (1994) Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients.
000235 (1993) [Bone marrow scintigraphy. Contribution to the diagnosis and the prognosis of myelofibrosis].
000241 (1993) Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
000258 (1992) Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
000268 (1991) Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis.
000269 (1991) Imaging of myocardial infarction in dogs and humans using monoclonal antibodies specific for human myosin heavy chains.
000279 (1990) Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
000284 (1990) Detection of prosthetic valve thrombosis using 111indium platelet imaging.
000295 (1988) [Development of left intraventricular thrombi. Monitoring by two-dimensional echocardiography and scintigraphy with indium 111-labelled platelets].
000300 (1988) Comparison of two-dimensional echocardiography with scanography and indium-111 platelet scintigraphy in detection of intracardiac thrombi.
000111 (2005) Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study.
000130 (2003) Octreotide imaging plus bone scintigrams to optimally localize gastroenteropancreatic neuroendocrine tumors.
000141 (2001) [Radio-guided resection of residual metastatic lymph node from a previously resected neuroendocrine tumor].
000161 (1999) Subarachnoid-pleural fistula complicating thoracoscopy: value of In-111 DTPA myeloscintigraphy.
000167 (1999) False-positive antimyosin imaging caused by cardioversion-induced skeletal muscle uptake.
000178 (1998) Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo.
000184 (1997) Utility of indium-111-antimyosin scintigraphy for diagnosis of myocardial damage in systemic sclerosis.
000192 (1997) Effects of preoperative intentional hemodilution on the extravasation rate of albumin and fluid.
000195 (1996) Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor.
000198 (1996) Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
000203 (1996) Functional upregulation of granulocytes labeled with technetium-99m-HMPAO and indium-111-oxinate.
000212 (1995) Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium-111 octreotide: can we predict the response to chemotherapy in small cell lung cancer?
000226 (1994) Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor.
000242 (1993) Platelet production in idiopathic thrombocytopenic purpura.
000243 (1993) New application of myocardial antimyosin scintigraphy: diagnosis of myocardial disease in polymyositis.

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024